BridgeBio Pharma, Inc. (BBIO) › Shares OutstandingBridgeBio Pharma, Inc. (BBIO) — Shares OutstandingAnnual figures by period end, from SEC filings.2018-12-31: 92.06M2019-12-31: 123.66M2020-12-31: 122.85M2021-12-31: 147.34M2022-12-31: 150.63M2023-12-31: 175.08M2024-12-31: 190.04M2025-12-31: 194.77M194.77M2018-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-31194.77M+2.5%2026-02-24Balance as of period end2024-12-31190.04M+8.5%2026-02-24Balance as of period end2023-12-31175.08M+16.2%2025-02-20Balance as of period end2022-12-31150.63M+2.2%2024-02-22Balance as of period end2021-12-31147.34M+19.9%2023-02-23Balance as of period end2020-12-31122.85M-0.7%2022-02-25Balance as of period end2019-12-31123.66M+34.3%2021-02-25Balance as of period end2018-12-3192.06M—2020-03-03Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)